STAT3 and neoplasm: Because it has been reported that inhibition of JAK/STAT3 directly impairs adipose tissue lipolysis43, we treated non-tumor bearing mice with ruxolitinib until they reached weight stability, and then calorie restricted them to promote lipolysis.